Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fresenius Kabi is a global healthcare company specializing in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. The company's product portfolio includes a comprehensive range of IV generic drugs, infusion therapies, and clinical nutrition products, such as the SmofKaviben multi-chamber bag system. SmofKaviben is a specialized parenteral nutrition solution containing a unique four-oil lipid emulsion (SMOF), amino acids, electrolytes, and dextrose. Beyond nutrition, Fresenius Kabi is a significant player in the biosimilars market, developing treatments for oncology and autoimmune diseases. The company also provides medical devices and transfusion technology for the collection and processing of blood components. Their operations span manufacturing and R&D across Europe, North America, and Asia, serving critically and chronically ill patients worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SmofKaviben.